| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Rengui Hong CEO | XSHE Exchange | CNE100000LZ9 ISIN |
| CN Country | 930 Employees | 11 Jun 2026 Last Dividend | 15 May 2018 Last Split | 5 Mar 2010 IPO Date |
Founded in 2001, Qianjiang Yongan Pharmaceutical Co., Ltd. is based in Qianjiang, China, and primarily focuses on the manufacture and sale of taurine within the Chinese market. This company distinguishes itself by engaging in a variety of operational sectors, including scientific research, technical service provision, as well as wholesale and retail trade. Additionally, Qianjiang Yongan Pharmaceutical extends its business activities to leasing and business services along with crop farming, showcasing a diverse portfolio beyond its core pharmaceutical manufacturing functions.
A vital component in the company’s product lineup, taurine is manufactured for various applications across food, beverage, and pharmaceutical industries. Taurine is known for its benefits to heart and muscle health, as well as its role in supporting neurological development.
This chemical compound is produced for its broad use in making solvents, antifreeze, textiles, detergents, and as a sterilizing agent for medical equipment and supplies. Qianjiang Yongan’s production of ethylene oxide caters to multiple industrial sectors.
The company manufactures water reducers, which are essential additives in the construction industry. These chemicals are used to enhance the workability of concrete, reducing the need for water in concrete mixtures without compromising the concrete's structural integrity.
Capitalizing on its pharmaceutical roots, Qianjiang Yongan Pharmaceutical also develops and markets a variety of health products. These are aimed at improving overall well-being, demonstrating the company’s commitment to leveraging its scientific expertise for health enhancement.
In addition to product manufacturing, the company is deeply engaged in scientific research aimed at innovating within its field. Alongside this, it provides technical services related to its product lines and research findings, offering expertise to clients.
Qianjiang Yongan Pharmaceutical operates in both the wholesale and retail sectors, distributing its products widely. This allows for greater market penetration and accessibility of its product offerings to various consumer segments.
The company provides leasing and specific business services, offering solutions that complement its main manufacturing activities. This portfolio expansion aligns with strategic diversification efforts and customer service enhancement.
Exploring agricultural ventures, Qianjiang Yongan Pharmaceutical engages in crop farming. This unusual diversification for a pharmaceutical company may contribute to its sustainability goals or complement its raw materials supply chain for product manufacturing.